736MO Personalized, off-the-shelf KRAS neoantigen-specific immunotherapy for the treatment of advanced solid tumors: Clinical benefit associated with decreases in ctDNA (SLATE-KRAS)

Autor:	C.K. Kyi, A. Spira, D.P. Carbone, M.L. Johnson, B.S. Henick, B. Johnson, H. Borghaei, A. Mahipal, J.R. Hecht, D. Catenacci, C-Y. Liao, A. Shergill, R. Memmott, C. Presley, J. Jaroslavsky, D. Schenk, K. Jooss, A.R. Ferguson, J.W. Goldman
Rok vydání:	2022
Předmět:	Oncology Hematology
Zdroj:	Annals of Oncology. 33:S880
ISSN:	0923-7534
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::efbb0b5184085f536dc40692ef1a7c23 https://doi.org/10.1016/j.annonc.2022.07.862 Zobrazit plný text záznamu